Luncheon Symposium

<Navigating Urological Oncology: Best Approaches for Advanced Prostate and Bladder Cancer in Today's Era>

This symposium brings together world-renowned experts in urological oncology and a multidisciplinary panel to share cutting-edge insights on two key topics:

Optimizing the use of GnRH antagonists for prostate cancer patients with existing cardiovascular risk factors, while maintaining treatment intensification strategies.

Exploring the evolving treatment landscape of non-muscle invasive bladder cancer, focusing on novel intravesical therapies.

The experts will delve into practical considerations for maximizing the efficacy of anticancer agents, illustrated with real-world case studies on mitigating cardiovascular toxicities in prostate cancer management.